You are here

Study Evaluating Vaccine in Adults With HIV

Last updated on February 22, 2019

FOR MORE INFORMATION
Study Location
Sacramento, California, 95817 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
HIV Infections
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- 18 years of age diagnosed with HIV and on stable HAART for a minimum of six months

- CD4 T-cell count greater than and equal to 350/mm3 at screening

- No reported CD4 T-cell count less than 350/mm3 at any time before screening

- Viral load less than 50 copies/mL at screening and no viral load greater than 400
copies/mL for a minimum of six months prior to screening

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Any chronic symptomatic infection other than HIV

- Use of any prior HIV vaccine (prophylactic and/or therapeutic) within one year before
or during screening

- Any malignancy that may require systemic therapy

- Use of any investigational treatment within six months before screening or planned
during study enrollment, except for investigational retrovirals obtained through ACTG

NCT00195234
Pfizer
Completed
Study Evaluating Vaccine in Adults With HIV

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Cryptococcal Meningitis, HIV Infections
NCT00002294
All Genders
18+
Years
Multiple Sites
HIV Infections, Pneumococcal Infections
NCT00963235
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now